MétaCan
Menu
← Back to cohort
Record W2912750114 · doi:10.1093/ecco-jcc/jjy222.598

P474 Analysis of UC colectomy rates in pre- and post-biologic era in South-East Scotland

2019· article· en· W2912750114 on OpenAlexaboutno aff
Philip Jenkinson, Gareth‐Rhys Jones, Nikolas Plevris, Mathew Lyons, Kathryn Kirkwood, Charlie W. Lees

Bibliographic record

VenueJournal of Crohn s and Colitis · 2019
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineColectomyInfliximabGolimumabVedolizumabAdalimumabMedical prescriptionGeneral surgeryUlcerative colitisSurgeryDatabaseInternal medicineDisease

Abstract

fetched live from OpenAlex

Anti-TNF treatment reduces requirement for surgical resection in CD; but whether biologic agents reduce colectomy rates in UC is not clear. Between February 2015 and June 2015, NICE and the Scottish Medicines Consortium approved the use of infliximab, adalimumab, golimumab and vedolizumab for medically refractory UC. Prior to this date biologic use in UC across Scotland was restricted to infliximab rescue therapy. We therefore aimed to describe UC colectomy rates before and after the advent of biologic use for moderately to severely active UC. We performed a retrospective analysis of UC colectomy rates in a single Scottish health board (NHS Lothian) from January 2009 to December 2017. Surgical resections for UC were identified from the Lothian Pathology database and/or theatre record. Electronic medical records were screened to describe UC phenotype and operation details. Colectomies were termed ‘elective’ if operative decision was made prior to admission, ‘emergency’ if colectomy occurred during admission and ‘fulminant’ if within 3 months of diagnosis. Biologic prescriptions details for all UC patients from January 2009 to June 2017 were retrieved from the Edinburgh Biologics Registry. Extent and severity of disease were defined using the Montreal classification at colectomy or at initiation of biologic for those who did not undergo colectomy. Linear regression was used to assess change in rates of colectomy and biologic use over the study period. There was a reduction in annual colectomy rate during the overall study period (p = 0.028) (Figure 1), with 39 (30–44) median (IQR) colectomies between 2009 and 14 and 25 (23–26) between 2014 and 17. This was driven by a reduction in non-fulminant colectomy rate (p = 0.028); there was no change in the rate of fulminant colectomies. Over the same time, in keeping with national guidelines in Feb 2015, there was a significant increase in biologic prescribing (p < 0.001). In total, 296 patients underwent colectomy consisting of 193 (65%) emergency and 97 (33%) elective operations (Table 1). The first age pouch operation has seen a significant decline over the study period. Figure 1. Colectomy rate per year divided by ‘fulminant’ cases performed within 3 months of diagnosis vs. ‘non-fulminant’ cases performed after 3 months of diagnosis. p denotes significance for the trend during follow-up. Table 1. Details of colectomy procedures performed for UC per year from 2009 to 2017. Increased use of biologics has been matched by an overall reduction in colectomy rates. However, this has been driven by fewer operations in those who have established UC with fulminant colectomy rates unchanged over time.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.060
Threshold uncertainty score0.119

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.004
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0030.003
Science and technology studies0.0000.001
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.004
GPT teacher head0.230
Teacher spread0.226 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Crohn s and Colitis→Same topicInflammatory Bowel Disease→French-language works237,207→